An overview of growth hormone therapy in pediatric cases documented in the Kabi International Growth Study (Pfizer International Growth Database)

An overview of growth hormone therapy in pediatric cases documented in the Kabi International Growth Study (Pfizer International Growth Database)

The Kabi International Growth Study (KIGS) was first established in 1987 and is the largest pharmaco-epidemiological study of recombinant human growth hormone (rhGH). KIGS is aimed at evaluating long-term safety and treatment outcomes in pediatric subjects who received Genotropin rhGH therapy (Pfize...

Full description

Bibliographic Details
Main Authors: Mitchell E. Geffner, Michael B. Ranke, Michael P. Wajnrajch, for the Pfizer International Growth Database Strategic Executive Committee, Strategic Advisory Board, and International Board
Format: Article
Language:English
Published: Korean Society of Pediatric Endocrinology 2024-02-01
Series:Annals of Pediatric Endocrinology & Metabolism
Subjects:
kabi international growth study
pharmaco-epidemiological study
recombinant human growth hormone
Online Access:http://e-apem.org/upload/pdf/apem-2346206-103.pdf

Internet

http://e-apem.org/upload/pdf/apem-2346206-103.pdf

Similar Items